GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Epigenomics AG (STU:ECX) » Definitions » Cyclically Adjusted Book per Share

Epigenomics AG (STU:ECX) Cyclically Adjusted Book per Share : €51.45 (As of Jun. 2023)


View and export this data going back to . Start your Free Trial

What is Epigenomics AG Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Epigenomics AG's adjusted book value per share for the three months ended in Jun. 2023 was €2.237. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €51.45 for the trailing ten years ended in Jun. 2023.

During the past 12 months, Epigenomics AG's average Cyclically Adjusted Book Growth Rate was -9.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -15.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -13.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Epigenomics AG was -11.40% per year. The lowest was -15.40% per year. And the median was -11.40% per year.

As of today (2024-05-26), Epigenomics AG's current stock price is €1.59. Epigenomics AG's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2023 was €51.45. Epigenomics AG's Cyclically Adjusted PB Ratio of today is 0.03.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Epigenomics AG was 6.18. The lowest was 0.03. And the median was 0.59.


Epigenomics AG Cyclically Adjusted Book per Share Historical Data

The historical data trend for Epigenomics AG's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epigenomics AG Cyclically Adjusted Book per Share Chart

Epigenomics AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 88.86 85.25 76.28 59.28 52.55

Epigenomics AG Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.24 57.55 52.55 53.16 51.45

Competitive Comparison of Epigenomics AG's Cyclically Adjusted Book per Share

For the Diagnostics & Research subindustry, Epigenomics AG's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epigenomics AG's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Epigenomics AG's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Epigenomics AG's Cyclically Adjusted PB Ratio falls into.



Epigenomics AG Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Epigenomics AG's adjusted Book Value per Share data for the three months ended in Jun. 2023 was:

Adj_Book= Book Value per Share /CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=2.237/123.1404*123.1404
=2.237

Current CPI (Jun. 2023) = 123.1404.

Epigenomics AG Quarterly Data

Book Value per Share CPI Adj_Book
201309 44.968 98.983 55.943
201312 70.153 99.356 86.947
201403 70.972 99.543 87.797
201406 51.809 99.543 64.091
201409 31.799 99.823 39.227
201412 56.068 99.543 69.360
201503 39.090 99.717 48.272
201506 70.558 100.417 86.525
201509 58.913 100.417 72.245
201512 55.903 99.717 69.035
201603 40.726 100.017 50.142
201606 64.094 100.717 78.364
201609 42.916 101.017 52.315
201612 90.375 101.217 109.950
201703 76.859 101.417 93.322
201706 53.067 102.117 63.992
201709 81.490 102.717 97.693
201712 62.745 102.617 75.294
201803 45.589 102.917 54.547
201806 29.899 104.017 35.396
201809 10.078 104.718 11.851
201812 78.919 104.217 93.249
201903 66.928 104.217 79.080
201906 49.621 105.718 57.799
201909 37.842 106.018 43.954
201912 34.712 105.818 40.395
202003 20.882 105.718 24.323
202006 24.361 106.618 28.136
202009 18.458 105.818 21.480
202012 12.865 105.518 15.014
202103 10.960 107.518 12.553
202106 10.760 108.486 12.213
202109 40.994 109.435 46.128
202112 28.469 110.384 31.759
202203 23.338 113.968 25.216
202206 20.378 115.760 21.677
202209 17.036 118.818 17.656
202212 12.427 119.345 12.822
202303 5.550 122.402 5.583
202306 2.237 123.140 2.237

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Epigenomics AG  (STU:ECX) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Epigenomics AG's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.59/51.45
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Epigenomics AG was 6.18. The lowest was 0.03. And the median was 0.59.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Epigenomics AG Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Epigenomics AG's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Epigenomics AG (STU:ECX) Business Description

Traded in Other Exchanges
Address
Geneststrasse 5, Berlin, BB, DEU, 10829
Epigenomics AG is a molecular diagnostics company, that focuses on developing and commercializing in vitro diagnostic liquid biopsy tests for the screening, early detection, and diagnosis of cancer. The company develops and markets procedures and devices for the production in quantity of particular epigenetic parameters such as DNA methylation patterns as well as the information technology bases necessary for their procurement and evaluation. It is engaged in the development of novel molecular diagnostic products for cancer. The company products include Epi proColon, Epi BiSKit, HCCBloodTest, and Epi proLung. The company operates in Europe, Asia, and North America, majority of its revenue derives from Asia.

Epigenomics AG (STU:ECX) Headlines